Alzheimer’s Drug Discovery Foundation:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9318
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alzheimer’s Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation. The foundation offers funds for drug discovery and development research programs in the field of Alzheimer’s disease, related dementias and cognitive aging. It offers services and support for development of drugs to prevent, treat, and cure Alzheimer’s disease. ADDF provides grants to the recipients for the treatment of Alzheimer’s disease. The foundation provides funds on preclinical research and early-stage clinical trials for new drug targets. It partners with various universities, and other research and development organizations. ADDF is headquartered in New York, the US.

Alzheimer’s Drug Discovery Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
M3 Biotechnology Raises USD15.2 Million in Venture Financing 10
M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12
Partnerships 13
Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer’s Disease Drugs 13
Equity Offering 14
Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14
Alzheimer’s Drug Discovery Foundation – Key Competitors 15
Alzheimer’s Drug Discovery Foundation – Key Employees 16
Alzheimer’s Drug Discovery Foundation – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
May 10, 2018: $2.5 Million in New Funding Exemplifies ADDF’s Strategy 18
Apr 12, 2018: Inaugural Memories Matter Benefit Raises $1.2 Million for Alzheimers Drug Research 21
Mar 28, 2018: Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute Invite Applications for 2018 ADDF-Harrington Scholar Award 22
Mar 13, 2018: Funding Supports New Approaches to Treat Multiple Types of Dementia 23
Jan 09, 2018: Alzheimer’s Drug Discovery Foundation: $2.5 Million in New Grants Advance Clinical Trials of Alzheimers Treatments 24
Jan 08, 2018: Alzheimer’s Drug Discovery Foundation: $1.8 Million in New Funding Supports Clinical Stage Treatments 25
Jan 08, 2018: $1.8 Million in New Funding Supports Clinical Stage Treatments 27
Nov 14, 2017: Alzheimer’s Drug Discovery Foundation Announces Three New Grants 29
Sep 12, 2017: Three New Grants Support Promising Treatments for Alzheimers Disease 30
Sep 05, 2017: New Funding Supports Blood Test for Early Alzheimer’s 31
May 15, 2017: $2.6 Million in New Grants Spurs Innovation 32
Apr 20, 2017: ADDF-Funded Scientists Discover Two Repurposed Drugs With Promise for Alzheimers and FTD 35
Mar 07, 2017: $4 Million in New Grants Support Several First-in-class Dementia Treatments 36
Mar 01, 2017: Cypralis Announces Grant Award from Alzheimer’s Drug Discovery Foundation 39
Jan 09, 2017: $2.5 Million in New Grants Advance Clinical Trials of Alzheimer’s Treatments 40
Product News 42
Nov 01, 2017: New Report Highlights Innovation in Alzheimers Clinical Trials 42
Jun 07, 2017: The Alzheimer’s Drug Discovery Foundation and Science Exchange Launch ADDF ACCESS to Advance CNS Research 43
Other Significant Developments 44
Jun 07, 2017: ADDF and Science Exchange Launch ADDF ACCESS to Advance Research 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alzheimer's Drug Discovery Foundation, Deals By Therapy Area, 2012 to YTD 2018 8
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
M3 Biotechnology Raises USD15.2 Million in Venture Financing 10
M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12
Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer's Disease Drugs 13
Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14
Alzheimer's Drug Discovery Foundation, Key Competitors 15
Alzheimer's Drug Discovery Foundation, Key Employees 16

List of Figures
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Alzheimer’s Drug Discovery Foundation:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aiphone Co Ltd (6718):企業の財務・戦略的SWOT分析
    Aiphone Co Ltd (6718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Diebold Nixdorf, Incorporated:企業の戦略・SWOT・財務情報
    Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Western Refining, Inc. (WNR)-石油・ガス分野:企業M&A・提携分析
    Summary Western Refining, Inc. (Western Refining) is a downstream oil and gas company that refines crude and markets its derivatives. The company’s product portfolio comprises gasoline, diesel fuel, jet fuel, and asphalt. The company operates refineries in El Paso, Texas; Gallup, Mexico; and St. Pau …
  • Aquion Energy Inc:電力:M&Aディール及び事業提携情報
    Summary Aquion Energy Inc (Aquion) is a diversified company. The company manufactures and markets saltwater batteries. It offers bulk energy storage modules, M-line battery modules, and S-line battery stacks. Aquion utilizes Aqueous Hybrid Ion battery technology to provide long-duration energy stora …
  • Kuzbasskaya Toplivnaya Company:企業の戦略・SWOT・財務分析
    Kuzbasskaya Toplivnaya Company - Strategy, SWOT and Corporate Finance Report Summary Kuzbasskaya Toplivnaya Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • MDC Holdings Inc:企業の戦略・SWOT・財務情報
    MDC Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary MDC Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Mereo Biopharma Group Plc (MPH):企業の財務・戦略的SWOT分析
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • Empresas Publicas De Medellin ESP:企業の戦略的SWOT分析
    Empresas Publicas De Medellin ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Painted Pony Energy Ltd (PONY):石油・ガス:M&Aディール及び事業提携情報
    Summary Painted Pony Energy Ltd (Painted Pony Energy), formerly Painted Pony Petroleum Ltd is a natural gas producer that offers production development drilling for natural gas and natural gas liquids. The company offers development of its premium, sweet natural gas resource base located in the opti …
  • Navamedic ASA (NAVA):医療機器:M&Aディール及び事業提携情報
    Summary Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, food supplements and other healthcare products. …
  • Bayer AG (BAYN):医療機器:M&Aディール及び事業提携情報
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products for human and animal health care, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications. The company's pr …
  • Advanced Biological Laboratories SA-製薬・医療分野:企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …
  • DSW Inc.:企業の戦略・SWOT・財務情報
    DSW Inc. - Strategy, SWOT and Corporate Finance Report Summary DSW Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Casey’s General Stores, Inc.:企業の戦略・SWOT・財務情報
    Casey's General Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Casey's General Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • QEP Resources Inc (QEP):企業の財務・戦略的SWOT分析
    QEP Resources Inc (QEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Compania Espanola de Petroleos SAU:企業の戦略・SWOT・財務情報
    Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report Summary Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):製薬・医療:M&Aディール及び事業提携情報
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) is engaged in the manufacturing of traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, chemical medicines, dietary supplements, pharmaceutical raw m …
  • AT&T Inc:戦略・SWOT・企業財務分析
    AT&T Inc - Strategy, SWOT and Corporate Finance Report Summary AT&T Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Bank Sohar SAOG (BKSB):企業の財務・戦略的SWOT分析
    Bank Sohar SAOG (BKSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Naim Holdings Berhad:企業の戦略・SWOT・財務情報
    Naim Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Naim Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆